CareMax Q3 EPS $(0.92) May Not Be Comparable To $(0.12) Estimate, Sales $201.84M Beat $194.71M Estimate
Portfolio Pulse from Benzinga Newsdesk
CareMax reported Q3 losses of $(0.92) per share, missing the analyst consensus estimate of $(0.12) by 666.67%. This is a 268% decrease from the same period last year. However, the company reported quarterly sales of $201.84 million, beating the analyst consensus estimate of $194.71 million by 3.66%. This is a 28.02% increase from the same period last year.
November 09, 2023 | 11:57 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
CareMax's Q3 earnings per share missed estimates significantly, but sales beat estimates. This mixed result could lead to uncertainty in the market.
CareMax's earnings per share missed estimates by a large margin, which could negatively impact the stock. However, the company's sales beat estimates, which could have a positive impact. The mixed results could lead to uncertainty in the market, making it difficult to predict the short-term price direction.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100